Marianne Ulcickas Yood

Summary

Affiliation: Josephine Ford Cancer Center
Country: USA

Publications

  1. pmc Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy
    Marianne Ulcickas Yood
    EpiSource, Newton, MA, USA
    Pharmacoepidemiol Drug Saf 21:818-27. 2012
  2. doi request reprint Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia
    Marianne Ulcickas Yood
    EpiSource, LLC, Newton, MA, USA
    Curr Med Res Opin 28:213-9. 2012
  3. ncbi request reprint The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy
    Marianne Ulcickas Yood
    Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Pharmacoepidemiol Drug Saf 15:852-60. 2006
  4. ncbi request reprint Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection
    Marianne Ulcickas Yood
    Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
    Hepatology 46:107-12. 2007
  5. ncbi request reprint Using prescription claims data for drugs available over-the-counter (OTC)
    Marianne Ulcickas Yood
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Pharmacoepidemiol Drug Saf 16:961-8. 2007
  6. ncbi request reprint Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm
    M Ulcickas Yood
    Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
    J Viral Hepat 15:28-36. 2008
  7. doi request reprint The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study
    Marianne Ulcickas Yood
    EpiSource, Hamden, CT, USA
    Pharmacoepidemiol Drug Saf 18:791-9. 2009
  8. doi request reprint Epidemiologic study of aripiprazole use and the incidence of suicide events
    Marianne Ulcickas Yood
    EpiSource, Newton, MA, USA
    Pharmacoepidemiol Drug Saf 19:1124-30. 2010
  9. pmc Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
    Marianne Ulcickas Yood
    EpiSource, LLC, Newton, MA, USA
    BMC Psychiatry 11:197. 2011
  10. ncbi request reprint Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy
    Marianne Ulcickas Yood
    EpiSource, Hamden, CT, USA
    Am Heart J 152:777-84. 2006

Collaborators

Detail Information

Publications31

  1. pmc Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy
    Marianne Ulcickas Yood
    EpiSource, Newton, MA, USA
    Pharmacoepidemiol Drug Saf 21:818-27. 2012
    ..To quantify incidence of cardiovascular outcomes in patients with advanced breast cancer receiving cardiotoxic and non-cardiotoxic chemotherapy...
  2. doi request reprint Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia
    Marianne Ulcickas Yood
    EpiSource, LLC, Newton, MA, USA
    Curr Med Res Opin 28:213-9. 2012
    ..This study evaluates real-world adherence in patients diagnosed with CML receiving dasatinib or nilotinib as second-line therapy...
  3. ncbi request reprint The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy
    Marianne Ulcickas Yood
    Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Pharmacoepidemiol Drug Saf 15:852-60. 2006
    ..The objective of this study was to quantify the associations between NSAIDs and COX-2 inhibitors and risk for initiating antihypertensive therapy...
  4. ncbi request reprint Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection
    Marianne Ulcickas Yood
    Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
    Hepatology 46:107-12. 2007
    ..80, 95% confidence interval = 1.16-6.75), after controlling for age, race, sex, income, Charlson comorbidity index, study site, and HCV infection...
  5. ncbi request reprint Using prescription claims data for drugs available over-the-counter (OTC)
    Marianne Ulcickas Yood
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Pharmacoepidemiol Drug Saf 16:961-8. 2007
    ..The purpose of this study is to quantify the effect of misclassification of OTC use in research that uses prescription claims data as the sole source of exposure information...
  6. ncbi request reprint Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm
    M Ulcickas Yood
    Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
    J Viral Hepat 15:28-36. 2008
    ..8, 95% CI: 25.9-55.1). The magnitude of the relative increase in HCC risk seen using different criteria used to define HBV infection indicate that these automated data algorithms can identify patients with chronic HBV infection...
  7. doi request reprint The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study
    Marianne Ulcickas Yood
    EpiSource, Hamden, CT, USA
    Pharmacoepidemiol Drug Saf 18:791-9. 2009
    ....
  8. doi request reprint Epidemiologic study of aripiprazole use and the incidence of suicide events
    Marianne Ulcickas Yood
    EpiSource, Newton, MA, USA
    Pharmacoepidemiol Drug Saf 19:1124-30. 2010
    ..To fulfill a postmarketing request, our objective was to determine suicide event (attempted or completed) incidence in patients with schizophrenia or bipolar disorder, prescribed aripiprazole...
  9. pmc Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
    Marianne Ulcickas Yood
    EpiSource, LLC, Newton, MA, USA
    BMC Psychiatry 11:197. 2011
    ..The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose...
  10. ncbi request reprint Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy
    Marianne Ulcickas Yood
    EpiSource, Hamden, CT, USA
    Am Heart J 152:777-84. 2006
    ..No population-based studies have examined the effect of race on achieving target low-density lipoprotein (LDL) goals among treated individuals...
  11. ncbi request reprint Time to pharmacotherapy change in response to elevated HbA1c test results
    Marianne Ulcickas Yood
    EpiSource, 275 Blue Trail, Hamden, CT 06518, USA
    Curr Med Res Opin 22:1567-74. 2006
    ..This study describes the clinical management of type 2 diabetes among a cohort of patients receiving oral antidiabetic monotherapy...
  12. ncbi request reprint An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications
    Marianne Ulcickas Yood
    Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
    Curr Med Res Opin 22:307-14. 2006
    ....
  13. ncbi request reprint What do medical records tell us about potentially harmful co-prescribing?
    Jennifer Elston Lafata
    Center for Health Services Research, Henrry Ford Health System, Detroit, USA
    Jt Comm J Qual Patient Saf 33:395-400. 2007
    ..Previous efforts document drug-drug interactions in ambulatory care. Yet little is known about medical record documentation or clinical management when interacting medications are received...
  14. ncbi request reprint Potential drug-drug interactions in the outpatient setting
    Jennifer Elston Lafata
    Henry Ford Health System, Detroit, Michigan 48202, Channing Laboratory, Brigham and Women s Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Med Care 44:534-41. 2006
    ..Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern...
  15. pmc Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
    Clin Epidemiol 1:93-100. 2009
    ..Low subject prevalence in the highest strata of a comorbidity index often prompts combination of upper categories into a single stratum ('collapsing')...
  16. ncbi request reprint Mortality impact of less-than-standard therapy in older breast cancer patients
    Marianne Ulcickas Yood
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    J Am Coll Surg 206:66-75. 2008
    ....
  17. ncbi request reprint Routine surveillance care after cancer treatment with curative intent
    Jennifer Elston Lafata
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Med Care 43:592-9. 2005
    ..Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations...
  18. ncbi request reprint Prescription drug use in pregnancy
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
    Am J Obstet Gynecol 191:398-407. 2004
    ..The purpose of this study was to provide information on the prevalence of the use of prescription drugs among pregnant women in the United States...
  19. ncbi request reprint The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events
    Paul Stang
    Galt Associates, Inc, Blue Bell, PA 19422, USA
    Am J Ther 14:30-40. 2007
    ..Coprescribing of medications not compatible with statins occurs frequently. The extent of coprescribing indicates the need for additional intervention to assure that the risk of untoward effects is mitigated...
  20. ncbi request reprint Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    Felix M Arellano
    Risk Management Resources, LLC Bridgewater, NJ 08807, USA
    Pharmacoepidemiol Drug Saf 15:861-72. 2006
    ..COX-2 and NSAIDS differ in their gastrointestinal (GI) and cardiovascular (CV) toxicity from pharmacological, clinical and epidemiologic point of views...
  21. ncbi request reprint Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Stephen H Taplin
    Group Health Cooperative, Seattle, WA, USA
    J Natl Cancer Inst 96:1518-27. 2004
    ..However, despite high national mammography screening rates, late-stage breast cancers still occur, possibly because of failures in screening implementation...
  22. doi request reprint Administrative data used to identify patients with irritable bowel syndrome
    Sarah L Goff
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA 01605, USA
    J Clin Epidemiol 61:617-21. 2008
    ..To assess the usefulness of health plan administrative data for identifying patients with irritable bowel syndrome (IBS)...
  23. pmc Breast cancer treatment of older women in integrated health care settings
    Shelley M Enger
    Department of Research and Evaluation, Kaiser Permanente Medical Care Program, Pasadena, CA, USA
    J Clin Oncol 24:4377-83. 2006
    ..We sought to identify patient and tumor characteristics associated with the nonreceipt of standard primary tumor and systemic adjuvant therapies...
  24. ncbi request reprint Use of prescription medications with a potential for fetal harm among pregnant women
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:546-54. 2006
    ..To estimate the prevalence of use of prescription drugs with a potential for fetal harm among pregnant women in the United States...
  25. ncbi request reprint Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
    Cynthia Owusu
    Division of Hematology Oncology, Case Western Reserve University, University Hospitals Health System Ireland Cancer Center BHC 5055, 11100 Euclid Ave, Cleveland, OH 44106 5055, USA
    J Clin Oncol 26:549-55. 2008
    ..However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer...
  26. pmc Under utilization of surveillance mammography among older breast cancer survivors
    Terry S Field
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    J Gen Intern Med 23:158-63. 2008
    ..Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems...
  27. pmc Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers
    Joan Fortuny
    Epidemiology and Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Gastroenterol Hepatol 5:1154-1159.e3. 2007
    ..We investigated whether use of LES-relaxing drugs was related to an increased risk of esophageal and gastric cardia adenocarcinoma, and whether use of NSAIDs was related to a reduced risk of esophageal and gastric cancers...
  28. ncbi request reprint Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone
    Douglas W Mapel
    Lovelace Clinic Foundation, Albuquerque, NM 87106, USA
    COPD 4:127-34. 2007
    ..The treatment benefit is reproducible and is robust to application of a number of different analysis techniques designed to adjust for differences in confounding variables and for bias by indication...
  29. ncbi request reprint Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications?
    Gregory S Cooper
    Division of Gastroenterology and Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106 5066, USA
    Med Care 44:590-4. 2006
    ..After potentially curative cancer treatment, patients may receive procedures for routine monitoring for recurrence or for evaluation of symptoms or signs...
  30. ncbi request reprint Using probabilistic corrections to account for abstractor agreement in medical record reviews
    Timothy L Lash
    Boston University School of Public Health, Boston, MA 02118, USA
    Am J Epidemiol 165:1454-61. 2007
    ..While many investigators use reliability data only as a metric for data quality, a more thorough approach can also quantitatively depict the uncertainty in the observed associations...
  31. ncbi request reprint Treatment and referral patterns for colorectal cancer
    Susan A Oliveria
    Galt Associates, Inc, Sterling, Virginia, USA
    Med Care 42:901-6. 2004
    ..National guidelines recommend adjuvant chemotherapy for colorectal cancer stages III, and IV; however, it has been shown that only 45-55% of these patients receive chemotherapy...